ETFs
S
SLDB
Solid Bioscience
6.39
+0.47+7.85%Opening13:01 10/20 EDT
OPEN/PREV CLOSE5.93/5.92
TODAY RANGE5.86-6.52
VOL741.07K
MARKET CAP684.63M
52 WEEK RANGE3.790-11.45
AVG VOL (3M)1.15M
% TURNOVER0.69%
TURNOVER--
P/E (TTM)-3.3464
% RANGE11.15%
EPS(TTM)-1.9080
P/E(FORWARD)-3.6905
P/B1.794
BVPS3.558
DIVIDEND--
P/S11.93
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP602.53M
SHARES OUTSTANDING107.23M
NEXT EARNINGS11/02-11/06
FREE FLOAT94.37M
LOT SIZE1
EX-DATE10/28/2022
News
Press Releases
Financial Reports
Profile
TipRanks·5h ago
Leerink Partners Remains a Buy on Solid Biosciences (SLDB)
TipRanks·3d ago
SLDB, APPS, RDW, BAC, SMG Trending With Analysts
NASDAQ·3d ago
UBS Initiates Coverage of Solid Biosciences at Buy
Dow Jones·4d ago
Solid Biosciences Price Target Announced at $20.00/Share by UBS
TipRanks·5d ago
Solid Biosciences initiated with a Buy at UBS
Benzinga·10/09 21:05
12 Health Care Stocks Moving In Friday's After-Market Session
Seeking Alpha·09/25 10:49
Solid Biosciences: A Funded Challenge To Duchenne Gene Therapy's Limitations
NASDAQ·09/16 21:57
RBC Capital Initiates Coverage of Solid Biosciences at Outperform
Seeking Alpha·09/16 16:15
Solid Biosciences wins new Outperform at RBC on DMD opportunity
TipRanks·09/16 12:55
Cantor Fitzgerald Sticks to Its Buy Rating for Solid Biosciences (SLDB)
Same Industry
Name/Symbol
Change%
Price